[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR101814429B1 - A medical syringe - Google Patents

A medical syringe Download PDF

Info

Publication number
KR101814429B1
KR101814429B1 KR1020160012770A KR20160012770A KR101814429B1 KR 101814429 B1 KR101814429 B1 KR 101814429B1 KR 1020160012770 A KR1020160012770 A KR 1020160012770A KR 20160012770 A KR20160012770 A KR 20160012770A KR 101814429 B1 KR101814429 B1 KR 101814429B1
Authority
KR
South Korea
Prior art keywords
injection
therapeutic agent
body fluid
space
injection tube
Prior art date
Application number
KR1020160012770A
Other languages
Korean (ko)
Other versions
KR20170091906A (en
Inventor
구익모
전주희
김낙현
임재관
Original Assignee
메디브레인랩 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메디브레인랩 주식회사 filed Critical 메디브레인랩 주식회사
Priority to KR1020160012770A priority Critical patent/KR101814429B1/en
Publication of KR20170091906A publication Critical patent/KR20170091906A/en
Application granted granted Critical
Publication of KR101814429B1 publication Critical patent/KR101814429B1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M1/0009—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3135—Syringe barrels characterised by constructional features of the proximal end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3148—Means for causing or aiding aspiration or plunger retraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A medical syringe according to an embodiment of the present invention includes: an injection main body having a needle at a front end thereof and having a main body space therein; An injection tube having a front end communicating with the injection needle and a rear end located in the body space; A second infusion tube located in a body fluid storage space and a body fluid storage space in which body fluids are stored and communicable with the outside of the body fluid storage space is provided and the rear end of the infusion tube is located in the body fluid storage space, The negative pressure generated in the main body space is moved to the body fluid storage space through the second injection tube while the injection needle is retracted from the front end of the injection body in a state where the injection needle is inserted into the target body, A body fluid remover which sucks body fluid from a subject through a tube and stores the body fluid in a body fluid storage space; And a therapeutic agent storage space in which a therapeutic agent is stored. After the body fluid remover is separated from the main injection unit, the rear end of the injection tube is inserted into the main injection unit to communicate with the therapeutic agent storage space, And a therapeutic agent injection unit for pressing the therapeutic agent in the storage space so that the therapeutic agent is discharged through the injection tube and the injection needle.

Description

A MEDICAL SYRINGE

The present invention relates to a medical syringe, and more particularly, to a medical syringe capable of simultaneous removal of body fluids and injection of a therapeutic agent even in a single scan operation in the treatment of a tongue such as a ganglion.

The ganglion is a positive scab resulting from the swelling of jelly-like liquid in the thin film of the joint. In addition to the wrist, the gonadal tendon often occurs in joints with large movements such as the shoulder and back of the hand, palms, fingers, ankles, and toes, or in adjacent areas of the tendon around the joints, and rarely in the nerves or wrists.

When the ganglion develops, there is a tingling or stinging pain in the area where the ganglion develops and its surroundings. For example, wrist ganglion can cause severe pain when breaking a wrist, putting on the floor, lifting a heavy object, and so on. Treatment of wrist ganglion is a method of suctioning a ganglion with a syringe or a method of extruding a ganglion by externally compressing it. Surgical treatment also treats wrist ganglion with an incision.

Treatment of ganglion using a syringe is carried out by injecting a therapeutic agent after sucking the contents such as jelly in the syringe with a syringe. In the course of these treatments, syringes for extracting body fluids from the scrotum and injecting therapeutic agents are used separately. Thus, when a syringe for fluid removal and a syringe for injecting a therapeutic agent are used separately, the clinician must stab the injection needle twice or more in the human body, and the patient must suffer from the pain caused by the injection of the syringe more than once .

Korean Utility Model Publication No. 20-2012-0006364 discloses an extractor for biopsy using a fine needle.

An object of the present invention is to provide a medical syringe capable of performing fluid removal in a scum and injecting a therapeutic agent even in a single scanning operation at the time of treating a tongue such as a ganglion.

A medical syringe according to an embodiment of the present invention includes: an injection main body having a needle at a front end thereof and having a main body space therein; An injection tube having a front end communicating with the injection needle and a rear end located in the body space; A second infusion tube located in a body fluid storage space and a body fluid storage space in which body fluids are stored and communicable with the outside of the body fluid storage space is provided and the rear end of the infusion tube is located in the body fluid storage space, The negative pressure generated in the main body space is moved to the body fluid storage space through the second injection tube while the injection needle is retracted from the front end of the injection body in a state where the injection needle is inserted into the target body, A body fluid remover which sucks body fluid from a subject through a tube and stores the body fluid in a body fluid storage space; And a therapeutic agent storage space in which a therapeutic agent is stored. After the body fluid remover is separated from the main injection unit, the rear end of the injection tube is inserted into the main injection unit to communicate with the therapeutic agent storage space, And a therapeutic agent injection unit for pressing the therapeutic agent in the storage space so that the therapeutic agent is discharged through the injection tube and the injection needle.

In one embodiment of the present invention, the body fluid remover includes a body fluid storage body provided with a body fluid storage space; And a first sealing member which is provided at a front end of the body fluid storage body to seal the body fluid storage space and through which the injection tube is inserted when the body fluid storage body is inserted into the injection body portion, And communicates with the body space at the time of insertion into the injection body portion of the body fluid storage body so as to provide the sound pressure generated in the body body space to the body fluid storage space when the body fluid storage body moves backward with respect to the injection body portion.

In one embodiment of the present invention, it is preferable that the second injection tube has a S-shaped bent structure to prevent the body fluid stored in the body fluid storage space from being transferred to the body space.

In one embodiment of the present invention, the therapeutic agent injection unit includes a therapeutic agent storage body inserted into the injection body part so as to be movable back and forth in the body space; A second sealing member which is coupled to the front end of the therapeutic agent storage body to seal the inside of the therapeutic agent storage body and penetrate the injection tube when inserted into the injection body of the therapeutic agent storage body; And a movable seal member which is spaced apart from the second seal member and movably installed in the therapeutic agent storage body and seals the therapeutic agent storage space, wherein the movable seal member is provided at a rear end of the injection tube at the time of insertion into the injection body portion of the therapeutic agent storage body The therapeutic agent is moved backward toward the rear end of the therapeutic agent storage body by the pushing force of the injection tube at the time of forward movement to the injection body portion of the therapeutic agent storage body so that the therapeutic agent is pressed through the injection tube and the injection needle So that it is injected into the human tissue.

In one embodiment of the present invention, the mobile sealing member is provided with a through hole sealed by a thin film, and is inserted into the injection tube at the time of insertion into the injection body of the therapeutic agent storage body, absence; And a movable movable plate coupled to the injection tube support member so as to surround the outer surface of the injection tube support member and inserted into the therapeutic agent storage body so as to be in intimate contact with the inner surface of the therapeutic agent storage body, When the therapeutic agent storage body is moved forward toward the front end of the injection body, the rear end of the injection tube is opened while communicating with the injection tube at the time of inserting the injection tube, It is preferable to pressurize the therapeutic agent in the therapeutic agent storage space while being moved backward to be away from the second sealing member by the stuck force.

In one embodiment of the present invention, it is preferable that the rear end of the injection tube has a sloped cross section so as to easily penetrate the thin film sealing the through hole.

In an embodiment of the present invention, an outer surface of the injection body portion is provided with a body opening communicated with the body space and covered by the cover film, and the cover film is separated from the body opening to release the sound pressure generated in the body space, So as to be easily separated from the injection body portion.

The present invention can simultaneously perform body fluid removal and therapeutic agent injection in a single operation, that is, in a state in which the injection needle is inserted into the human body once, at the time of treatment of the splenic tendon. Therefore, the present invention can reduce the degree of pain applied to the patient in the process of injecting the needle into the human body several times in the process of treating the ganglion.

1 schematically shows a perspective view of a medical syringe according to an embodiment of the present invention.
Fig. 2 schematically shows a cross-sectional view cut along AA of Fig.
3 schematically shows a state in which the body fluid remover is inserted into the injection main body part in an embodiment of the present invention.
4 schematically shows a cross-sectional view of a state in which the therapeutic agent injection part is inserted into the injection body part, in an embodiment of the present invention.
Figure 5 schematically illustrates an operating state diagram of a bodily fluid remover against an injection body portion in one embodiment of the present invention.
Fig. 6 schematically shows an operating state of the therapeutic agent infusion section with respect to the injection main body section, in an embodiment of the present invention.

Hereinafter, a medical syringe according to a preferred embodiment of the present invention will be described with reference to the accompanying drawings.

1, a medical syringe 100 according to an embodiment of the present invention includes a main body 110, an injection tube 120, a body fluid remover 130, and a therapeutic agent injection unit 150 . The present invention can remove the body fluid from the human body tissue 10 even when the injection needle 112 pierces the human body tissue 10 with the swelling once, and can inject the therapeutic agent with the swallowing.

As shown in FIGS. 1 and 2, the injection main body 110 includes a syringe body 111 and an injection needle 112. A needle 112 is provided at the front end of the syringe body 111. The syringe body 111 has a structure in which the rear end is opened. The syringe body 111 is provided with a body space 113 into which the body fluid removing unit 130 and the therapeutic agent injecting unit 150 are inserted.

On the outer surface of the syringe body 111, a body opening 115a is provided at a position adjacent to the front end of the syringe body 111. [ The main body opening 115a is an opening communicating with the main body space 113 and the outside. The body opening 115a is sealed by the cover film 115. [

The cover film 115 may be formed in a thin film shape having a material enough to withstand the negative pressure generated in the body space 113. The cover film 115 is pierced by an externally applied force to open the body opening 115a. When the main body opening 115a is opened, the negative pressure state of the main body space 113 is released.

An injection tube 120 is installed in the syringe body 111. The injection tube 120 is a passage through which the body fluid and the therapeutic agent move. The front end of the injection tube 120 communicates with the injection needle 112. The rear end 121 of the injection tube is positioned in the body space 113.

The rear end 121 of the injection tube has a sloped cross section. With this structure, when the therapeutic agent injection section is inserted into the injection main body section, the injection tube 120 passes through the through hole 155c of the injection tube support member 155b, which will be described later, Can be fitted to the injection tube support member 155b to be described later in a state in which entry into the through hole 155c is limited.

Hereinafter, the bodily fluid remover will be described.

3 and 5, the body fluid remover 130 is inserted into the injection body 110, and after the injection needle 112 of the injection body is inserted into the body tissue 10 in which body fluids are present, It is intended to remove body fluids from swallowing. For example, body fluids are caused by gangrene, such as ganglion.

The body fluid removing unit 130 is inserted into the injection body 110 such that the injection tube 120 is positioned in the body fluid storage space 136 and the body fluid storage space 136 communicates with the body space 113. [ At this time, the body fluid storage space 136 and the body space 113 communicate with each other to form a closed space.

The body fluid remover 130 includes a body fluid storage body 131, a first sealing member 133, and a second injection tube 135. The body fluid storage body 131 is provided with a body fluid storage space 136 therein. The body fluid storage space 136 is a space where the body fluid is stored. The body fluid storage space 136 is sealed by a first sealing member 133 coupled to the front end of the body fluid storage body 131.

The first sealing member 133 is inserted through the injection tube 120 when the body fluid storage body 131 is inserted into the syringe body 111 and when the body fluid storage body 131 is moved backward with respect to the syringe body 111 And may be made of an elastic material movable in a state of being in intimate contact with the inner surface of the syringe body 111.

The first sealing member 133 closely contacts the inner surface of the syringe body 111 and seals the body space 113 when the body fluid storage body 131 is inserted into the syringe body 111.

The second injection tube 135 is for communicating the body space 113 and the body fluid storage space 136 when the body fluid storage body 131 is inserted into the syringe body 111. The front end of the second injection pipe 135 is fixed to the first sealing member 133. The rear end of the second injection tube 135 is located in the body fluid storage space 136. The second injection tube 135 is a passage through which the sound pressure of the body space 113 is transferred to the body fluid storage space 136 when the body fluid storage body 131 is inserted into the syringe body 111.

The second injection tube 135 has a S-shaped bent structure to prevent the body fluid stored in the body fluid storage space 136 from being transferred to the body space 113.

When the body fluid storage body 131 is inserted into the syringe body 111, the body space 113 is sealed by the cover film 115 and the first sealing member 133, and the body fluid storage space 136 is sealed 2 injection tube 135, but is sealed by the first sealing member 133. [ Thus, the main body space 113 and the body fluid storage space 136 are maintained in a sound pressure state.

The sound pressure trapped in the main body space 113 while the body fluid storage body 131 is moved backward with respect to the syringe body 111 in the state in which the injection needle 112 is inserted into the body tissue 10, And the body fluid in the swirling vortex is sucked into the body fluid storage space 136 through the injection needle 112 and the injection tube 120 by the negative pressure so as to be introduced into the body fluid storage space 136 .

Hereinafter, the therapeutic agent injection unit will be described.

The therapeutic agent injection part is inserted into the injection body part so as to provide the therapeutic agent with the needle inserted through the injection tube and the injection needle.

4 and 6, the therapeutic agent injection unit 150 is provided with a therapeutic agent storage space 156 in which a therapeutic agent is stored.

The therapeutic agent injecting unit 150 is inserted into the injection main body unit 110 so that the injection tube 120 is communicated with the therapeutic agent storage space 156 in a state where the body fluid removing unit 130 is separated from the injection body unit 110 The therapeutic agent in the therapeutic agent storage space may be pressurized while being moved forward toward the front end of the injection main body 110 so that the therapeutic agent is injected through the injection tube 120 and the injection needle 112.

The therapeutic agent injection unit 150 includes a therapeutic agent storage body 151, a second sealing member 153, and a moving seal member 155.

Therapeutic drug storage body 151 is inserted into scan main body 110 so as to be movable back and forth. The therapeutic agent storage body 151 is connected to the injection tube 120 so that the therapeutic agent is injected into the injection tube 120. The therapeutic agent storage body 151 is provided with a therapeutic agent storage space 156 in which a therapeutic agent is stored.

The front end of the therapeutic agent storage body 151 is sealed by the second sealing member 153. [ The second sealing member 153 is provided with a second through hole 153a. The second through hole 153a is an opening through which the injection tube 120 passes when the therapeutic agent storage body 151 is inserted into the syringe body 111. [

The second sealing member 153 closely contacts the inner surface of the syringe body 111 to seal the body space 113 when the therapeutic agent storage body 151 is inserted into the syringe body 111. [ The second sealing member 153 may be made of an elastic material movable in a state of being in intimate contact with the inner surface of the syringe body 111 when the therapeutic agent storage body 151 is moved forward with respect to the syringe body 111.

The therapeutic agent storage body 151 is provided with a movable sealing member 155. The movable sealing member 155 is movably installed in the therapeutic agent storage body 151 away from the second sealing member 153. The transferring sealing member 155 is located between the second sealing member 153 and the rear end of the therapeutic agent storage body and divides the interior of the therapeutic agent storage body 151 into the therapeutic agent storage space 156 and the empty space 154 And the therapeutic agent storage space 156 is sealed. The empty space 154 is a space formed between the second sealing member 153 and the moving sealing member 155 and is a space in which the injection tube 120 penetrating the second sealing member 153 is located.

4, the movable sealing member 155 is fitted to the rear end 121 of the injection tube when the therapeutic agent storage body 151 is inserted into the syringe body 111. [ The movement seal member 155 is moved backward by the pushing force of the injection tube 120 when the therapeutic agent storage body 151 is moved forward to the injection main body portion 110 to pressurize the therapeutic agent in the therapeutic agent storage space 156, And is injected into the human body tissue 10 through the tube 120.

The moving seal member 155 is composed of a moving seal plate 155a and an injection tube support member 155b.

The injection tube support member 155b is for supporting the injection tube 120 such that the rear end 121 of the injection tube passes through the through hole 155c and communicates with the therapeutic agent storage space 156. [ The injection tube support member 155b is provided with a through hole 155c at the center thereof. The through hole 155c is an opening through which an inclined portion of the rear end 121 of the injection tube passes.

The injection tube support member 155b is made of a material having a strength higher than that of the injection tube 120 so as to withstand the force applied to the injection tube 120 when the therapeutic agent storage body 151 is moved forward to the syringe body 111 .

The moving seal plate 155a surrounds the outer surface of the injection tube support member 155b and has a shape that can come into close contact with the inner surface of the therapeutic agent storage body 151. [ The moving seal plate 155a seals the therapeutic agent storage space 156 so that the therapeutic agent stored in the therapeutic agent storage space 156 is not introduced into the empty space 154 of the therapeutic agent storage body 151. [ At this time, the through hole 155c is sealed with a material which is easily pierced by the rear end 121 of the injection tube.

The movement sealing plate 155a is made of an elastic material similar to the first sealing member 133 and the second sealing member 153 so that when the force is applied by the injection tube supporting member 155b, The therapeutic agent stored in the therapeutic agent storage space 156 is pressurized while being moved backward in close contact.

Hereinafter, the process of removing body fluids from the human body 10 will be described with reference to FIG.

In order to remove the body fluid from the body tissue 10, the injection body 110 and the body fluid remover 130 are used. 5 (a), the clinician may insert the injection needle 112 into the body tissue 10 (FIG. 5) in which the body fluid eliminator 130 is inserted into the injection body 110, ).

Thereafter, as shown in Fig. 5 (b), the clinician pulls the body fluid storage body 131 in the F1 direction. At this time, the body fluid storage main body 131 is moved backward with respect to the syringe body 111 by the pulling force of the clinician, and the pressure of the body tissue 10 ) Is sucked into the body fluid storage space (136). In this process, the sound pressure of the body space 113 is transferred to the body fluid storage space 136 through the second injection tube 135. The main body space 113 forms a closed space by the cover film 115 and the first sealing member 133 to maintain a negative pressure state.

 5 (b), the clinician removes the body fluid in the body fluid storage space 136 from the cover film 115 after sucking a proper amount of body fluid to prevent the body fluid in the body fluid storage space 136 from flowing into the second infusion tube 135, The body fluid removing unit 130 can be separated from the syringe body 111 by releasing the sound pressure of the body space 113 by separating the body fluid from the main body opening 115a.

Next, with reference to FIG. 6, a process of injecting a therapeutic into the human tissue 10 will be described.

After the bodily fluid remover 130 is separated from the syringe body 111, the therapeutic agent injection section is inserted into the syringe body 111. As shown in Fig. 6 (a), the therapeutic agent injection portion is inserted into the syringe body 111 so that the rear end 121 of the injection tube is caught in the movable seal member 155. At this time, the therapeutic agent injection unit is in a state where the therapeutic agent is stored in the therapeutic agent storage space 156. The therapeutic agent storage space 156 is sealed by the movable sealing member 155, and the through hole 155c is also sealed. The through hole 155c is unsealed by the rear end 121 of the injection tube in the process of inserting the therapeutic agent injection portion into the syringe body 111. [

6 (a), when the therapeutic agent storage body 151 is moved forward with respect to the syringe body 111 in the F3 direction, the second sealing member 153 is moved along with the therapeutic agent storage body 151, (111).

6 (b), the movable sealing member 155 is moved in the F4 direction so as to be away from the second sealing member 153 by a force applied to the rear end 121 of the injection tube, (156). At this time, the therapeutic agent is injected into the human body tissue 10 through the injection tube 120.

The present invention can simultaneously perform body fluid removal and therapeutic agent injection in a single operation, that is, in a state in which the injection needle is inserted into the human body once, at the time of treatment of the splenic tendon. Therefore, the present invention can reduce the degree of pain applied to the patient in the process of injecting the needle into the human body several times in the process of treating the ganglion.

Although several embodiments of the present invention have been shown and described, those skilled in the art will appreciate that various modifications may be made without departing from the principles and spirit of the invention . The scope of the invention will be determined by the appended claims and their equivalents.

100: medical syringe 110: injection main body part
111: syringe body 112: needle
113: main body space 115: cover film
120: Injection tube 130:
131: body fluid storage body 133: first sealing member
135: Second infusion tube 136: Fluid storage space
150: Therapeutic drug infusion unit 151: Therapeutic drug storage unit
153: second sealing member 155: moving seal member
156: Therapeutic drug storage space

Claims (7)

An injection main body having an injection needle at a front end thereof and provided with a main body space therein;
An injection tube having a front end communicating with the injection needle and a rear end positioned in the main body space;
A body fluid storage space in which the body fluid is stored and a second injection tube disposed in the body fluid storage space and provided so as to be able to communicate with the outside of the body fluid storage space, a rear end of the injection tube is located in the body fluid storage space, A sound pressure generated in the main body space is transmitted through the second injection tube while being moved backward from the front end of the injection main body in a state where the injection needle is inserted into the target body in such a manner that the storage space communicates with the main body space, A body fluid remover which moves to the body fluid storage space and sucks the body fluid from the object through the injection needle and the injection tube and stores the body fluid in the body fluid storage space; And
A treatment agent storage space in which a therapeutic agent is stored is provided and after the body fluid removing part is separated from the injection main body part, a rear end of the injection tube is inserted into the injection main body part so as to communicate with the therapeutic agent storage space, And a therapeutic agent injecting unit for injecting the therapeutic agent through the injection tube and the injection needle by pressing the therapeutic agent in the therapeutic agent storage space while being moved forward toward the injection needle.
2. The apparatus according to claim 1,
A body fluid storage body provided with the body fluid storage space; And
And a first sealing member installed at a front end of the body fluid storage body to seal the body fluid storage space and to penetrate the injection tube when the body fluid storage body is inserted into the injection body,
Wherein the second infusion tube is coupled to the first sealing member and communicates with the body space when the body fluid storage body is inserted into the injection body portion so that when the body fluid storage body is moved backward relative to the injection body portion, And a sound pressure generated in the space is supplied to the body fluid storage space.
3. The method of claim 2,
Wherein the second injection tube has a S-shaped bent structure to prevent the body fluid stored in the body fluid storage space from being transferred to the body space.
The therapeutic agent injection device according to claim 1,
A therapeutic agent storage body inserted into the injection main body part so as to be movable back and forth in the main body space;
A second sealing member coupled to a front end of the therapeutic agent storage body to seal the interior of the therapeutic agent storage body and to penetrate the injection tube when inserted into the injection body of the therapeutic agent storage body; And
And a movable seal member which is spaced apart from the second sealing member and is movably installed in the therapeutic agent storage body and seals the therapeutic agent storage space,
Wherein the movable seal member is in contact with the rear end of the injection tube at the time of insertion of the therapeutic agent storage body into the injection body portion, and when the therapeutic agent storage body is advanced to the injection body portion, Wherein the therapeutic agent is pressurized in the therapeutic agent storage space while being moved backward toward the rear end of the storage body so that the therapeutic agent is injected into the human tissue through the injection tube and the injection needle.
5. The mobile terminal according to claim 4,
An injection tube supporting member provided with a through hole sealed by a thin film and fitted to the injection tube at the time of insertion into the injection body of the therapeutic agent storage body to support the injection tube; And
And a moving seal plate coupled to the injection tube support member so as to surround the outer surface of the injection tube support member and inserted into the therapeutic agent storage body so as to be in intimate contact with the inner surface of the therapeutic agent storage body,
Wherein the through hole is opened when the therapeutic agent storage body is inserted into the injection body, the rear end of the injection tube being opened while communicating with the injection tube,
Wherein the movable sealing plate is moved backward by a force applied to the injection tube support member with respect to the rear end of the injection tube when the therapeutic agent storage body is moved forward toward the front end of the injection body portion, And pressurizing the therapeutic agent in the therapeutic agent storage space.
6. The method of claim 5,
Wherein a rear end of the injection tube has a sloped cross section so as to easily penetrate the thin film that has sealed the through hole.
The method according to claim 1,
An outer surface of the injection body portion is provided with a body opening communicated with the body space and covered by the cover film,
Wherein the cover film is separated from the main body opening to release a negative pressure generated in the main body space, so that the body fluid removing part is easily separated from the main body part.
KR1020160012770A 2016-02-02 2016-02-02 A medical syringe KR101814429B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160012770A KR101814429B1 (en) 2016-02-02 2016-02-02 A medical syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160012770A KR101814429B1 (en) 2016-02-02 2016-02-02 A medical syringe

Publications (2)

Publication Number Publication Date
KR20170091906A KR20170091906A (en) 2017-08-10
KR101814429B1 true KR101814429B1 (en) 2018-01-30

Family

ID=59652250

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160012770A KR101814429B1 (en) 2016-02-02 2016-02-02 A medical syringe

Country Status (1)

Country Link
KR (1) KR101814429B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510984A (en) * 1996-12-05 2002-04-09 エム ディー シー インベストメント ホールディングス，インコーポレイテッド Body fluid collection device with retractable needle
JP2004503285A (en) 2000-06-13 2004-02-05 エヌエムティー　グループ　パブリック　リミテッド　カンパニー Phlebotomy device
JP2004313797A (en) 2003-04-16 2004-11-11 Becton Dickinson & Co Needle assembly
JP2011212182A (en) * 2010-03-31 2011-10-27 Terumo Corp Prefilled syringe

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510984A (en) * 1996-12-05 2002-04-09 エム ディー シー インベストメント ホールディングス，インコーポレイテッド Body fluid collection device with retractable needle
JP2004503285A (en) 2000-06-13 2004-02-05 エヌエムティー　グループ　パブリック　リミテッド　カンパニー Phlebotomy device
JP2004313797A (en) 2003-04-16 2004-11-11 Becton Dickinson & Co Needle assembly
JP2011212182A (en) * 2010-03-31 2011-10-27 Terumo Corp Prefilled syringe

Also Published As

Publication number Publication date
KR20170091906A (en) 2017-08-10

Similar Documents

Publication Publication Date Title
US8617126B2 (en) Painless injector
JP4550808B2 (en) Therapeutic or diagnostic drug delivery device
US8545433B2 (en) Apparatus and method for treating spider veins
US8968243B2 (en) Device and method for delivering medicine into the tympanic cavity,with sliding assist
CN101112638B (en) Vessel having a safeguard device and introducing needle component
CN101732083B (en) Trocar and trocar set
CN101827622B (en) Injection device
CN1083395A (en) medicament injection device
CN1658918A (en) Safety shield for medical needles
US8696640B2 (en) Snake venom evacuation and medication injection device
CN103841932A (en) Apparatus for intraocular injection
CN105579084A (en) drug delivery device
US3896805A (en) Multi-chamber syringe
WO2007113318A1 (en) Injector system for needleless, high pressure delivery of a medicament
CN101112639A (en) Vessel having a safeguard device and introducing needle component
KR20170054688A (en) A double syringe
KR101814429B1 (en) A medical syringe
JP2010517691A (en) Syringe assembly having anti-reuse mechanism
CN106267521A (en) Safety device, conduit and introducing needle assembly and remaining needle
CN103876872A (en) Fast exchanging imbedding device with smaller wave pipe
KR20180026494A (en) Improved medical connector
CN103007396A (en) Injection device used under medical endoscope
CN108261590A (en) A kind of dressing cylinder reuses injection device
US11975177B2 (en) Subconjunctival injector and method
CN107072669B (en) Hemostatic clamp capable of cleaning bleeding point and oozing blood

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant